Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 4 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 32 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 6 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 17 |
NetGPI | no | yes: 0, no: 17 |
Term | Name | Level | Count |
---|---|---|---|
GO:0015934 | large ribosomal subunit | 4 | 17 |
GO:0022625 | cytosolic large ribosomal subunit | 5 | 17 |
GO:0032991 | protein-containing complex | 1 | 17 |
GO:0044391 | ribosomal subunit | 3 | 17 |
GO:1990904 | ribonucleoprotein complex | 2 | 17 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
GO:0005840 | ribosome | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043228 | non-membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 1 |
Related structures:
AlphaFold database: A4HEM3
Term | Name | Level | Count |
---|---|---|---|
GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 10 | 17 |
GO:0000470 | maturation of LSU-rRNA | 9 | 17 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 17 |
GO:0006364 | rRNA processing | 8 | 17 |
GO:0006396 | RNA processing | 6 | 17 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 17 |
GO:0006807 | nitrogen compound metabolic process | 2 | 17 |
GO:0008152 | metabolic process | 1 | 17 |
GO:0009987 | cellular process | 1 | 17 |
GO:0016070 | RNA metabolic process | 5 | 17 |
GO:0016072 | rRNA metabolic process | 7 | 17 |
GO:0034470 | ncRNA processing | 7 | 17 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 17 |
GO:0034660 | ncRNA metabolic process | 6 | 17 |
GO:0043170 | macromolecule metabolic process | 3 | 17 |
GO:0044237 | cellular metabolic process | 2 | 17 |
GO:0044238 | primary metabolic process | 2 | 17 |
GO:0046483 | heterocycle metabolic process | 3 | 17 |
GO:0071704 | organic substance metabolic process | 2 | 17 |
GO:0090304 | nucleic acid metabolic process | 4 | 17 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 17 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003735 | structural constituent of ribosome | 2 | 17 |
GO:0005198 | structural molecule activity | 1 | 17 |
GO:0003676 | nucleic acid binding | 3 | 1 |
GO:0003723 | RNA binding | 4 | 1 |
GO:0005488 | binding | 1 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 113 | 115 | PF00675 | 0.356 |
CLV_NRD_NRD_1 | 232 | 234 | PF00675 | 0.602 |
CLV_NRD_NRD_1 | 63 | 65 | PF00675 | 0.372 |
CLV_NRD_NRD_1 | 80 | 82 | PF00675 | 0.212 |
CLV_PCSK_FUR_1 | 229 | 233 | PF00082 | 0.603 |
CLV_PCSK_FUR_1 | 61 | 65 | PF00082 | 0.250 |
CLV_PCSK_KEX2_1 | 164 | 166 | PF00082 | 0.550 |
CLV_PCSK_KEX2_1 | 231 | 233 | PF00082 | 0.606 |
CLV_PCSK_KEX2_1 | 28 | 30 | PF00082 | 0.345 |
CLV_PCSK_KEX2_1 | 63 | 65 | PF00082 | 0.414 |
CLV_PCSK_KEX2_1 | 80 | 82 | PF00082 | 0.326 |
CLV_PCSK_PC1ET2_1 | 164 | 166 | PF00082 | 0.550 |
CLV_PCSK_PC1ET2_1 | 231 | 233 | PF00082 | 0.606 |
CLV_PCSK_PC1ET2_1 | 28 | 30 | PF00082 | 0.345 |
CLV_PCSK_SKI1_1 | 114 | 118 | PF00082 | 0.345 |
CLV_PCSK_SKI1_1 | 123 | 127 | PF00082 | 0.345 |
CLV_PCSK_SKI1_1 | 210 | 214 | PF00082 | 0.515 |
CLV_PCSK_SKI1_1 | 29 | 33 | PF00082 | 0.345 |
CLV_PCSK_SKI1_1 | 48 | 52 | PF00082 | 0.345 |
CLV_PCSK_SKI1_1 | 75 | 79 | PF00082 | 0.414 |
DEG_APCC_DBOX_1 | 113 | 121 | PF00400 | 0.356 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.527 |
DOC_ANK_TNKS_1 | 232 | 239 | PF00023 | 0.606 |
DOC_MAPK_gen_1 | 112 | 122 | PF00069 | 0.345 |
DOC_MAPK_gen_1 | 164 | 170 | PF00069 | 0.525 |
DOC_PP2B_LxvP_1 | 221 | 224 | PF13499 | 0.606 |
DOC_USP7_UBL2_3 | 108 | 112 | PF12436 | 0.356 |
DOC_USP7_UBL2_3 | 51 | 55 | PF12436 | 0.388 |
LIG_14-3-3_CanoR_1 | 174 | 183 | PF00244 | 0.616 |
LIG_14-3-3_CanoR_1 | 210 | 219 | PF00244 | 0.673 |
LIG_14-3-3_CanoR_1 | 81 | 91 | PF00244 | 0.393 |
LIG_Actin_WH2_2 | 126 | 144 | PF00022 | 0.345 |
LIG_FHA_1 | 126 | 132 | PF00498 | 0.345 |
LIG_FHA_1 | 211 | 217 | PF00498 | 0.444 |
LIG_LIR_Gen_1 | 128 | 137 | PF02991 | 0.345 |
LIG_LIR_Nem_3 | 145 | 150 | PF02991 | 0.428 |
LIG_LYPXL_yS_3 | 152 | 155 | PF13949 | 0.563 |
LIG_PCNA_yPIPBox_3 | 108 | 120 | PF02747 | 0.347 |
LIG_PCNA_yPIPBox_3 | 132 | 141 | PF02747 | 0.356 |
LIG_Pex14_2 | 126 | 130 | PF04695 | 0.345 |
LIG_PTB_Apo_2 | 124 | 131 | PF02174 | 0.345 |
LIG_PTB_Apo_2 | 197 | 204 | PF02174 | 0.526 |
LIG_PTB_Phospho_1 | 197 | 203 | PF10480 | 0.524 |
LIG_SH2_CRK | 150 | 154 | PF00017 | 0.567 |
LIG_SH2_NCK_1 | 187 | 191 | PF00017 | 0.683 |
LIG_SH2_PTP2 | 13 | 16 | PF00017 | 0.492 |
LIG_SH2_SRC | 90 | 93 | PF00017 | 0.370 |
LIG_SH2_STAP1 | 65 | 69 | PF00017 | 0.345 |
LIG_SH2_STAT5 | 13 | 16 | PF00017 | 0.492 |
LIG_SH2_STAT5 | 147 | 150 | PF00017 | 0.584 |
LIG_SH2_STAT5 | 167 | 170 | PF00017 | 0.337 |
LIG_SH2_STAT5 | 203 | 206 | PF00017 | 0.565 |
LIG_SH2_STAT5 | 90 | 93 | PF00017 | 0.356 |
LIG_SH3_3 | 15 | 21 | PF00018 | 0.639 |
LIG_TRFH_1 | 219 | 223 | PF08558 | 0.599 |
MOD_CK1_1 | 154 | 160 | PF00069 | 0.540 |
MOD_Cter_Amidation | 61 | 64 | PF01082 | 0.396 |
MOD_GlcNHglycan | 24 | 27 | PF01048 | 0.333 |
MOD_GlcNHglycan | 8 | 11 | PF01048 | 0.713 |
MOD_GSK3_1 | 2 | 9 | PF00069 | 0.508 |
MOD_LATS_1 | 208 | 214 | PF00433 | 0.529 |
MOD_PKA_1 | 63 | 69 | PF00069 | 0.484 |
MOD_PKA_2 | 243 | 249 | PF00069 | 0.589 |
MOD_PKA_2 | 63 | 69 | PF00069 | 0.271 |
MOD_PKB_1 | 61 | 69 | PF00069 | 0.484 |
MOD_Plk_4 | 12 | 18 | PF00069 | 0.658 |
MOD_Plk_4 | 125 | 131 | PF00069 | 0.345 |
MOD_Plk_4 | 243 | 249 | PF00069 | 0.589 |
MOD_SUMO_rev_2 | 68 | 77 | PF00179 | 0.347 |
TRG_ENDOCYTIC_2 | 13 | 16 | PF00928 | 0.492 |
TRG_ENDOCYTIC_2 | 152 | 155 | PF00928 | 0.563 |
TRG_ENDOCYTIC_2 | 167 | 170 | PF00928 | 0.506 |
TRG_ER_diArg_1 | 120 | 123 | PF00400 | 0.345 |
TRG_ER_diArg_1 | 61 | 64 | PF00400 | 0.490 |
TRG_ER_diArg_1 | 79 | 81 | PF00400 | 0.194 |
TRG_NLS_MonoExtN_4 | 229 | 235 | PF00514 | 0.599 |
TRG_Pf-PMV_PEXEL_1 | 114 | 118 | PF00026 | 0.356 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PBU7 | Leptomonas seymouri | 95% | 100% |
A0A0S4IU62 | Bodo saltans | 83% | 100% |
A0A0S4JDH9 | Bodo saltans | 24% | 73% |
A0A1D8PDL6 | Candida albicans (strain SC5314 / ATCC MYA-2876) | 42% | 100% |
A0A1X0NSK2 | Trypanosomatidae | 88% | 100% |
A0A3Q8INU3 | Leishmania donovani | 94% | 100% |
A0A3R7M5J8 | Trypanosoma rangeli | 76% | 100% |
A0A3S7WZH9 | Leishmania donovani | 93% | 100% |
A0A422NVF3 | Trypanosoma rangeli | 85% | 100% |
A0BD73 | Paramecium tetraurelia | 43% | 100% |
A0CEY2 | Paramecium tetraurelia | 43% | 100% |
A1RU38 | Pyrobaculum islandicum (strain DSM 4184 / JCM 9189 / GEO3) | 30% | 100% |
A2BME0 | Hyperthermus butylicus (strain DSM 5456 / JCM 9403 / PLM1-5) | 27% | 100% |
A3MU87 | Pyrobaculum calidifontis (strain DSM 21063 / JCM 11548 / VA1) | 31% | 100% |
A4HEM2 | Leishmania braziliensis | 100% | 100% |
A4I1V4 | Leishmania infantum | 93% | 94% |
A4WHQ9 | Pyrobaculum arsenaticum (strain DSM 13514 / JCM 11321 / PZ6) | 31% | 100% |
A5GFQ0 | Sus scrofa | 28% | 100% |
A8MDN0 | Caldivirga maquilingensis (strain ATCC 700844 / DSM 13496 / JCM 10307 / IC-167) | 28% | 100% |
B1Y8Q5 | Pyrobaculum neutrophilum (strain DSM 2338 / JCM 9278 / NBRC 100436 / V24Sta) | 27% | 100% |
C9ZS66 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 88% | 100% |
C9ZS67 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 88% | 100% |
E9AHB0 | Leishmania infantum | 94% | 100% |
E9AXZ8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
E9AXZ9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 88% |
O01802 | Caenorhabditis elegans | 46% | 100% |
O60143 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 43% | 100% |
P05426 | Rattus norvegicus | 48% | 98% |
P05737 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 41% | 100% |
P0DJ13 | Tetrahymena thermophila | 38% | 100% |
P11874 | Dictyostelium discoideum | 45% | 100% |
P14148 | Mus musculus | 49% | 95% |
P17937 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 36% | 100% |
P18124 | Homo sapiens | 49% | 100% |
P25457 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 42% | 100% |
P32100 | Drosophila melanogaster | 48% | 100% |
P40693 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 27% | 80% |
P60039 | Arabidopsis thaliana | 44% | 100% |
P60040 | Arabidopsis thaliana | 45% | 100% |
Q12213 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 41% | 100% |
Q4Q9H4 | Leishmania major | 94% | 100% |
Q4R506 | Macaca fascicularis | 48% | 100% |
Q58DT1 | Bos taurus | 49% | 100% |
Q5R9R4 | Pongo abelii | 49% | 100% |
Q5RAH8 | Pongo abelii | 30% | 100% |
Q5ZJ56 | Gallus gallus | 50% | 100% |
Q6BTA4 | Debaryomyces hansenii (strain ATCC 36239 / CBS 767 / BCRC 21394 / JCM 1990 / NBRC 0083 / IGC 2968) | 42% | 100% |
Q6C603 | Yarrowia lipolytica (strain CLIB 122 / E 150) | 45% | 100% |
Q6DKI1 | Homo sapiens | 31% | 100% |
Q6FSN6 | Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65) | 42% | 100% |
Q755A7 | Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) | 42% | 100% |
Q75ET5 | Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) | 28% | 87% |
Q7SBD5 | Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) | 41% | 100% |
Q8SS93 | Encephalitozoon cuniculi (strain GB-M1) | 29% | 100% |
Q8ZXN8 | Pyrobaculum aerophilum (strain ATCC 51768 / DSM 7523 / JCM 9630 / CIP 104966 / NBRC 100827 / IM2) | 31% | 100% |
Q9D8M4 | Mus musculus | 30% | 100% |
Q9LHP1 | Arabidopsis thaliana | 45% | 100% |
Q9SAI5 | Arabidopsis thaliana | 31% | 100% |
V5DR72 | Trypanosoma cruzi | 85% | 100% |